Form 4: Crexendo COO Sells Shares After Option Exercise

Crexendo's Chief Operating Officer, Douglas Walter Gaylor, exercised stock options and subsequently sold 10,000 shares of common stock for a profit.

Summary

• Douglas Walter Gaylor, Crexendo's Chief Operating Officer, exercised 10,000 stock options on November 7, 2025, at an exercise price of $2.25 per share.
• On November 10, 2025, Mr. Gaylor sold these 10,000 shares of common stock at a weighted average price of $7.174 per share, with prices ranging from $7.15 to $7.19.
• The sale was conducted under a Rule 10b5-1(c) trading plan established on December 11, 2024, when Mr. Gaylor was not aware of material nonpublic information.
• Following these transactions, Mr. Gaylor beneficially owns 243,135 shares of common stock and 22,000 stock options.

Sentiment

Score: 6

Explanation: The transaction is a routine insider sale under a 10b5-1 plan, indicating a planned liquidation of vested equity compensation. While a sale by an executive can sometimes be viewed negatively, the pre-planned nature and the significant profit realized are neutral to slightly positive for the executive, with minimal direct impact on company sentiment.

Positives

• The COO realized a significant profit from exercising options at $2.25 and selling shares at an average of $7.174, indicating a positive return on his equity compensation.
• The transaction was executed under a pre-arranged Rule 10b5-1(c) plan, which demonstrates planned and compliant insider trading.

Negatives

• The sale of 10,000 shares by a key executive could be perceived as a reduction in insider ownership, although it represents a small fraction of his total holdings.

Future Outlook

NA

Management Comments

• This sale was made pursuant to a plan intended to comply with Rule 10b5-1(c), previously entered into on December 11, 2024, at which time Mr. Gaylor was not aware of material nonpublic information.

Industry Context

NA

Stakeholder Impact

• Shareholders: The sale by a COO could be interpreted in various ways, but given it's a 10b5-1 plan and a small percentage of total holdings, the direct impact is likely minimal. It shows an executive monetizing vested compensation.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-planned sale of shares by a company executive following the exercise of stock options. Such transactions, especially when conducted under a Rule 10b5-1 plan, are generally not indicative of a change in the company's fundamental outlook or a signal for future stock performance. The executive realized a profit, which is positive for their personal finances, but the transaction itself does not provide new information to warrant a change in investment recommendation for the stock. Investors should continue to evaluate Crexendo based on its operational performance, financial results, and strategic initiatives.

Keywords

Crexendo, CXDO, Insider Trading, Form 4, Stock Options, Share Sale, Executive Compensation, Douglas Walter Gaylor, Rule 10b5-1